Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Osteoarthritis Therapeutics Market size was valued at USD 9.31 billion in 2024 and is set to exceed USD 21.63 billion by 2037, registering over 6.7% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of osteoarthritis therapeutics is evaluated at USD 9.84 billion.
The growth of the market can be attributed to the increased number of patients with osteoarthritis. Osteoarthritis is a type of arthritis that occurs when flexible tissue at the ends of bone wears down. The main factor for the rise of osteoarthritis is the increasing number of geriatric population. According to the report published by United Nations, there were 703 million people aged 65 years or over in the world in 2019. Hence on the back of the increasing geriatric population, the market is estimated to witness remarkable growth during the forecast period. Moreover, the World Obesity Atlas 2022 report published by the World Obesity Federation predicts that 1 billion people globally, including 1 in 7 men and 1 in 5 women will be living with obesity by 2030. Obesity is also a primary factor that contributes to the development of osteoarthritis. The excess weight adds pressure and stress on joint, and fat cells promote inflammation. Additionally, osteoarthritis is also caused by joint injuries such as bone fracture, cartilage, or ligament tear. Posttraumatic osteoarthritis is the occurrence of arthritis after a trauma or an accident. The condition is becoming common and it is estimated that approximately 10% of osteoarthritis cases of the knee, ankle, and hip are the result of trauma or accident. Owing to surging accidental cases the market is expected to grow during the forecast period.
Osteoarthritis Therapeutics Sector: Growth Drivers and Challenges
Growth Drivers
-
Increasing Patients with Osteoarthritis
- Growing Government Initiatives Worldwide
Challenges
-
Lack of Awareness among People
Osteoarthritis Therapeutics Market: Key Insights
Osteoarthritis Therapeutics Segmentation
The osteoarthritis therapeutics market is segmented by distribution channel into hospital, retail, and online pharmacies. Out of which, the hospital sub-segment is anticipated to hold the largest share in the market during the forecast period on account of a large number of patients getting admitted to the hospitals. As hospitals are equipped with ultra-modern machines and talented doctors, plenty of patients are seeking treatment in the hospitals.
Our in-depth analysis of the global market includes the following segments:
Drug Class |
|
Route of Administration |
|
Diseases Type |
|
Distribution Channel |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportOsteoarthritis Therapeutics Industry - Regional Synopsis
Regionally, the osteoarthritis therapeutics market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. North America industry is expected to dominate majority revenue share by 2037, on the back of the presence of ultra-modern healthcare infrastructure in the region. According to the data released by the Centers for Diseases Control and Prevention, osteoarthritis affects over 32.5 million US adults. On the back of rising cases of osteoarthritis in the USA, patients are looking for effective measures of relief. This is estimated to propel the market growth during the forecast period.
The market is also projected to grow outstandingly during the forecast period in the Asia Pacific region. The region is highly populous and has a large number of osteoarthritis patients. The data released by the National Institute of Health and Family Welfare (NIHFW) in 2017, osteoarthritis is the 2nd most common rheumatologic problem in India, and 70% of the people above 65 years show radiological evidence of osteoarthritis. Owing to this, the market growth is predicted to propel during the forecast period.

Companies Dominating the Osteoarthritis Therapeutics Landscape
- Sanofi-aventis Groupe
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- GlaxoSmithKline plc
- Pfizer Inc.
- Bayer AG
- Zimmer Biomet Holdings, Inc.
- Horizon Therapeutics plc
- Johnson & Johnson Services, Inc.
- Novartis AG
- Ferring Group
- Merck & Co., Inc
In the News
-
May 20, 2022: Pfizer Inc. joins hand with NetVation DL Medicine which is a privately held biotechnology company based in Chengdu.
-
April 28, 2022: Medtronic plc (MDT), a medical technology company, announced collaboration with GE to meet growing need for outpatient care.
Author Credits: Radhika Pawar
- Report ID: 195
- Published Date: Dec 23, 2024
- Report Format: PDF, PPT